Open access · CC-BY
via OpenAlex
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma
Nishanth Ulhas Nair, Qun Jiang, Jun Stephen Wei, Vikram Alexander Misra, Betsy Morrow, Chimene A. Kesserwan, Leandro C. Hermida, Joo Sang Lee, Idrees Mian, Jingli Zhang, Alexandra Lebensohn, Markku Miettinen, Manjistha Sengupta, Javed Iqbal Khan, Eytan Ruppin
Cell Reports Medicine · 2023 · ▲ 26 citations
Abstract
Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. A better understanding of mesothelioma genomics and transcriptomics could advance therapies. Here, we present a mesothelioma cohort of 122 patients along with their germline and tumor whole-exome and tumor RNA sequencing data as well as phenotypic and drug response information. We identify a 48-gene prognostic signature that is highly predictive of mesothelioma patient survival, including CCNB1, the expression of which is highly predictive of patient survival on its own. In addition, we analyze the transcriptomics data to study the tumor immune microenvironment and identify synthetic-lethality-based signatures predictive of response to therapy. This germline and somatic whole-exome sequencing as well as transcriptomics data from the same patient are a valuable resource to address important biological questions, including prognostic biomarkers and determinants of treatment response in mesothelioma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.xcrm.2023.100938
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Nair, N.U., Jiang, Q., Wei, J.S., Misra, V.A., Morrow, B., Kesserwan, C.A., Hermida, L.C., Lee, J.S., Mian, I., Zhang, J., Lebensohn, A., Miettinen, M., Sengupta, M., Khan, J.I., Ruppin, E., & Hassan, R. (2023). Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. <em>Cell Reports Medicine</em>. https://doi.org/10.1016/j.xcrm.2023.100938
Vancouver
Nair NU, Jiang Q, Wei JS, Misra VA, Morrow B, Kesserwan CA, et al. Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. Cell Reports Medicine. 2023. doi:10.1016/j.xcrm.2023.100938.
BibTeX
@article{nishanth2023Genomi,
title = {Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma},
author = {Nishanth Ulhas Nair and Qun Jiang and Jun Stephen Wei and Vikram Alexander Misra and Betsy Morrow and Chimene A. Kesserwan and Leandro C. Hermida and Joo Sang Lee and Idrees Mian and Jingli Zhang and Alexandra Lebensohn and Markku Miettinen and Manjistha Sengupta and Javed Iqbal Khan and Eytan Ruppin and Raffit Hassan},
journal = {Cell Reports Medicine},
year = {2023},
doi = {10.1016/j.xcrm.2023.100938},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Gene Therapy 2025
Open access · CC-BY
Transcriptomic Signatures in TP53 Positive and Negative Tumor Samples in NSCLC
BMC Bioinformatics 2020
Open access · CC-BY
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
Journal of Orthopaedic Surgery and Research 2020
Open access · CC-BY
Results of advanced core decompression in patients with osteonecrosis of the femoral head depending on age and sex—a prospective cohort study
International Journal of Molecular Sciences 2021
Open access · CC-BY
Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update
Scientific Reports 2024
Open access · CC-BY
Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis
Biomedicines 2021
Open access · CC-BY